financingAbivax SA raises €130m to advance obefaz...French Abivax SA has raised €130m capital led by TCGX to accelerate Phase III testing of its ulcerative colitis candidate obefazimod extend its cashflow. more ➔
financingPaleo raised € 12 m in Series A financin...Myoglobin producer Paleo NV has closed a € 12 m Series A round led by DSM Venturing and Planet A Ventures. more ➔
partnershipMinaris and LIfT BioSciences collaborate i...CDMO Minaris Regenerative Medicine GmbH is to manufacture the leukocyte infusion therapy N-LIfT for LIFT BioSciences. more ➔
partnershipPVH Corp joins fiber-to-fiber consortiumPVH Corp has joined fiber-to-fiber consortium that wants to make textile recycling sustainable by establishing standards for biorecycled textile fibre. more ➔
cardiovascular diseaseFree sugar linked to higher cardiovascular...A UK Biobank study suggests that higher intake of free sugars is associated with a higher risk to develop cardiovascular disease, UK researchers report in BMC Medicine. more ➔
BioeconomyAMsilk scaling up through Evonik collabora...Fermatation expert Evonik SE has entered into an agreement with the German recombinant silk producer AMSilk to produce industrial quantities of innovative, sustainable silk proteins. more ➔
partnershipHOOKIPA bags US$10m cancer milestone HOOKIPA has received a US$10m milestone under its 2022 agreement with Roche to develop an arenaviral immunotherapy for KRAS-mutated cancers. more ➔
Cydar Medical Ltd raises €10.5m in Serie...Cambridge-based endovascular surgical AI specialist Cydar Medical has completed a €10.5m (£9.3m) Series A funding round led by Pembroke Venture Capital Trust more ➔
Upping sustainability in pharma packagingHow to make pharma packaging sustainable was one of the major discussion topics at PHARMAPACK 2023. more ➔
financingEvonetix extends Series B financing to US$...British Evonetix Ltd has added US$$24m to its existing US$30m Series B financing round. The new financing was led by existing investor Foresite Capital. more ➔
